| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.4M | -0.4% |
| R&D Expense | $63.0M | +98.0% |
| SG&A Expense | $17.2M | +60.5% |
| Operating Income | -$77.8M | -93.9% |
| Income Tax | $0 | — |
| Net Income | -$62.8M | -205.8% |
| EPS (Basic) | -$5.58 | +56.9% |
| EPS (Diluted) | -$5.58 | +56.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $325.9M | +1161.5% |
| Short-term Investments | $144.6M | +72.1% |
| Accounts Receivable | $613K | +525.5% |
| Current Assets | $479.2M | +309.6% |
| Total Assets | $481.7M | +311.0% |
| Current Liabilities | $10.7M | +64.8% |
| Total Liabilities | $11.9M | +26.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.2M | -56.0% |
| Capital Expenditures | $511K | +254.9% |
| Investing Cash Flow | -$59.5M | +28.2% |
| Financing Cash Flow | $418.9M | +223.4% |
| Free Cash Flow | -$59.7M | -56.8% |
| Stockholders' Equity |
| $469.9M |
| +481.6% |